7Baggers
 TransCode Therapeutics appoints Michel Janicot as development officer  Investing.com India Mon, 17 Nov 2025 13:19:32 GMT

TransCode Therapeutics Inc
(NASDAQ:RNAZ) 

RNAZ stock logo

TransCode Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for treating metastatic disease. The Company's development pipeline includes TTX-MC138, TTX-siPD-L1 and TTX-RIGA, TTX-siLIN28B, and TCD-miR10b.

Founded: 2016
CEO / Co-Founder: Michael Dudley 
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology

Share this website to your friends